280 related articles for article (PubMed ID: 25987700)
41. Identifying long-term survivors among metastatic breast cancer patients undergoing primary tumor surgery.
Yoo TK; Chae BJ; Kim SJ; Lee J; Yoon TI; Lee SJ; Park HY; Park HK; Eom YH; Kim HS; Kim CJ; Shin MS; You SH; Song BJ
Breast Cancer Res Treat; 2017 Aug; 165(1):109-118. PubMed ID: 28573447
[TBL] [Abstract][Full Text] [Related]
42. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
[TBL] [Abstract][Full Text] [Related]
43. Best supportive care in patients with brain metastases and adverse prognostic factors: development of improved decision aids.
Nieder C; Norum J; Dalhaug A; Aandahl G; Engljähringer K
Support Care Cancer; 2013 Oct; 21(10):2671-8. PubMed ID: 23686380
[TBL] [Abstract][Full Text] [Related]
44. Comparison of Prognostic Indices in NSCLC Patients with Brain Metastases after Radiosurgery.
Gao HX; Huang SG; Du JF; Zhang XC; Jiang N; Kang WX; Mao J; Zhao Q
Int J Biol Sci; 2018; 14(14):2065-2072. PubMed ID: 30585269
[TBL] [Abstract][Full Text] [Related]
45. Validation of the graded prognostic assessment index for surgically treated patients with brain metastases.
Nieder C; Geinitz H; Molls M
Anticancer Res; 2008; 28(5B):3015-7. PubMed ID: 19031949
[TBL] [Abstract][Full Text] [Related]
46. New breast cancer recursive partitioning analysis prognostic index in patients with newly diagnosed brain metastases.
Niwińska A; Murawska M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2065-71. PubMed ID: 21596487
[TBL] [Abstract][Full Text] [Related]
47. Subclassification of recursive partitioning analysis Class II patients with brain metastases treated radiosurgically.
Yamamoto M; Sato Y; Serizawa T; Kawabe T; Higuchi Y; Nagano O; Barfod BE; Ono J; Kasuya H; Urakawa Y
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1399-405. PubMed ID: 22209155
[TBL] [Abstract][Full Text] [Related]
48. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
49. Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.
Hulsbergen AFC; Lamba N; Claes A; Kavouridis VK; Lin NU; Smith TR; Verhoeff JJC; Broekman MLD
World Neurosurg; 2019 Aug; 128():e157-e164. PubMed ID: 31035019
[TBL] [Abstract][Full Text] [Related]
50. Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases.
Furtner J; Berghoff AS; Albtoush OM; Woitek R; Asenbaum U; Prayer D; Widhalm G; Gatterbauer B; Dieckmann K; Birner P; Aretin B; Bartsch R; Zielinski CC; Schöpf V; Preusser M
Eur Radiol; 2017 Aug; 27(8):3167-3173. PubMed ID: 28050694
[TBL] [Abstract][Full Text] [Related]
51. Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models.
Marko NF; Xu Z; Gao T; Kattan MW; Weil RJ
Cancer; 2012 Aug; 118(15):3749-57. PubMed ID: 22180078
[TBL] [Abstract][Full Text] [Related]
52. Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?
Estabrook NC; Lutz ST; Johnson CS; Lo SS; Henderson MA
CNS Oncol; 2016; 5(2):69-76. PubMed ID: 26985694
[TBL] [Abstract][Full Text] [Related]
53. Validation of a novel prognostic index: BMS-Score for patients with brain metastases of small cell lung cancer.
Hou R; Li H; Cao J; Song X; Zhang X; Wang W
Ann Palliat Med; 2021 Jan; 10(1):29-36. PubMed ID: 33440957
[TBL] [Abstract][Full Text] [Related]
54. A nomogram for individualized estimation of survival among patients with brain metastasis.
Barnholtz-Sloan JS; Yu C; Sloan AE; Vengoechea J; Wang M; Dignam JJ; Vogelbaum MA; Sperduto PW; Mehta MP; Machtay M; Kattan MW
Neuro Oncol; 2012 Jul; 14(7):910-8. PubMed ID: 22544733
[TBL] [Abstract][Full Text] [Related]
55. Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement.
Nieder C; Marienhagen K; Dalhaug A; Aandahl G; Haukland E; Pawinski A
Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):447-52. PubMed ID: 24702741
[TBL] [Abstract][Full Text] [Related]
56. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors affecting the outcome of brain metastases from breast cancer.
Liu MT; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Huang CY; Liou CH
Support Care Cancer; 2006 Sep; 14(9):936-42. PubMed ID: 16575571
[TBL] [Abstract][Full Text] [Related]
58. Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries.
Nieder C; Andratschke NH; Geinitz H; Grosu AL
Med Sci Monit; 2012 Jul; 18(7):CR450-5. PubMed ID: 22739735
[TBL] [Abstract][Full Text] [Related]
59. Validity of prognostic grading indices for brain metastasis patients undergoing repeat radiosurgery.
Yamamoto M; Kawabe T; Higuchi Y; Sato Y; Nariai T; Watanabe S; Barfod BE; Kasuya H
World Neurosurg; 2014 Dec; 82(6):1242-9. PubMed ID: 25109592
[TBL] [Abstract][Full Text] [Related]
60. Prolonged survival after diagnosis of brain metastasis from breast cancer: contributing factors and treatment implications.
Honda Y; Aruga T; Yamashita T; Miyamoto H; Horiguchi K; Kitagawa D; Idera N; Goto R; Kuroi K
Jpn J Clin Oncol; 2015 Aug; 45(8):713-8. PubMed ID: 25981620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
